Overview

Eluxadoline Bile Acid Malabsorption (BAM) Study

Status:
Completed

Trial end date:
2020-04-28

Target enrollment:

Participant gender:

Summary

This study will evaluate the possibility of a differential effect of eluxadoline on altered bowel function in Irritable Bowel Syndrome with Diarrhea (IBS-D) participants with and without evidence of Bile Acid Malabsorption (BAM).

Phase:

Phase 4

Details

Lead Sponsor:

Allergan

Treatments:

Eluxadoline